Lead Healthcare.AI

AI, develops automation and intelligent system solutions for life science instruments and biopharmaceutical applications. The company focuses on applied technologies supporting pharmaceutical research, biomanufacturing, and laboratory operations. Its offerings support laboratory operations, bioprocess workflows, and system-level efficiency improvements. The company has established a comprehensive portfolio spanning core technologies, key components, and system-level solutions. It has launched over 20 high-end products—including AI-driven large models for intelligent cell recognition, "AI for Science" automation equipment, high-throughput AI imaging flow cytometers, fully automated stem/immune cell culture and preparation systems, AI-based organoid drug screening systems, single-cell multi-omics systems, and microfluidic system modules. The company generates revenue by developing, manufacturing, and selling life science instruments, biomanufacturing equipment, and AI-enabled automation solutions for research and biopharmaceutical customers.AI will continue to increase R&D investment in AI algorithms and models, AI data centers, core components, and systematic solutions. The company will deepen the integration of AI with life sciences, medical devices, biopharmaceuticals, biomanufacturing, and high-end scientific instruments; tackle critical "bottleneck" technologies in the high-end instrument sector; and continuously iterate on competitive AI-driven life science instruments and digital-intelligent biomanufacturing platforms.

1. Angel

   May 22, 2025

   Amount

   $14M

   Investors

   Locked